Moneycontrol PRO

business

Mangalam Drugs plans to enter HIV API space

Drugs for ailments like malaria and HIV are well-accepted in the market and it'll be an advantage for Mangalam Drugs, says Managing Director Govardhan Dhoot.

first published: May 17, 2016 11:23 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347